Latest:
Exploring Real-World Evidence Presented at ATA 2023
Medical professionals discuss the recently published real-world evidence presented at the American Thyroid Association 2023 Conference.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Young Son, PGY3
Latest:
Dr Son on Urinary and Bowel Anastomotic Leak in Bladder Cancer
Young Son, PGY3, discusses the future implications of findings from a study investigating the association between neoadjuvant chemotherapy and increased urinary and bowel anastomosis failure in patients with bladder cancer who are undergoing radical cystectomy.
Richard L. Martin III, MD, MPH
Latest:
A Challenge to Medical Oncology Training Programs: Promote Equity in Training
In her 2020 American Society of Clinical Oncology presidential address, “Equity: Every patient. Every day. Everywhere,” Lori J. Pierce, MD, challenges medical oncology to imagine a future when equity is considered a humanistic standard of oncology practice.
Michael J. Fallon, MD
Latest:
Dr Fallon on Guidelines for the Administration of Infection Prophylaxis in R/R Multiple Myeloma
Michael J. Fallon, MD, discusses guidelines for the use and administration of infection prophylaxis in relapsed/refractory multiple myeloma, as well as the future role of prophylactic immunization in this landscape.
Sanam Loghavi, MD
Latest:
Dr Loghavi on the Expansion of Genetically-Defined Subtypes in AML
Sanam Loghavi, MD, discusses the expansion of genetically-defined categories of acute myeloid leukemia in the World Health Organization classification, and how this affects the diagnosis of patients in this space.